Novel bioanalytical methodologies for detection of specific biomarkers are anticipated to improve diagnosis. In this context, European researchers are working on novel sensors capable of detecting biomolecules and cells in biological samples.
Current molecular-based assays for routine diagnosis of cancer may lack sensitivity or be suitable only for advanced stages of the disease. As a result, novel tools that evaluate the molecular profile of tumours at the genetic, epigenetic, transcriptomic and protein level are now being employed. However, their complexity and cost have hampered their routine use in clinical diagnosis.
Further details: Sensors in cancer diagnosis